Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 961-973
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.961
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.961
Procedure type | Indications | Relative contraindications |
Total proctocolectomy with end ileostomy | UC, CD refractory disease or neoplasia | None |
Restorative proctocolectomy (RP) with Ileoanal pouch | UC | Fecal incontinence |
Direct sphincter invasion by tumor | ||
Stage IV CRC | ||
Subtotal colectomy with ileorectal anastomosis | UC or CD with contraindication for RP | Rectal neoplasia |
Active rectal inflammation | ||
Segmental resection | UC or CD with Unifocal dysplasia or cancer and no active disease | Acute or chronic colonic inflammation |
CRC with comorbidity and age > 65 yr | ||
Diverting ostomy | UC or CD with Stage IV CRC with obstruction and/or severe comorbidity | None |
- Citation: Althumairi AA, Lazarev MG, Gearhart SL. Inflammatory bowel disease associated neoplasia: A surgeon’s perspective. World J Gastroenterol 2016; 22(3): 961-973
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/961.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.961